Ownership of Results and Data. All results and data generated from screening the Compound Supply by or for Senomyx under this Agreement shall be owned exclusively by Senomyx and shall be treated as Senomyx Confidential Information hereunder. Aurora will not provide to a Third Party the Materials provided by Senomyx to Aurora hereunder.
Ownership of Results and Data. All data and results arising from resTORbio’s activities under this Agreement, including but not limited to Development, clinical and regulatory data and Information generated for regulatory purposes relating to a Product will be owned by resTORbio.
Ownership of Results and Data. All data and results arising from the Parties’ activities under the License Agreement, including clinical and regulatory data and information generated for regulatory purposes relating to the MPAG Compounds or Products shall be jointly owned by the Parties. At least once per Calendar Quarter, each Party shall disclose to the other Party all such data and results arising from the Parties’ activities under the License Agreement which have not previously been disclosed to the other Party.
Ownership of Results and Data. All data and results arising from a Party’s activities under this Agreement, including activities conducted by or on behalf of such Party, its Affiliates or sublicensees, including Development, clinical and regulatory data and information generated for regulatory purposes relating to Licensed Compound or Licensed Product will be owned by such Party, subject to the rights and licenses granted hereunder (as applicable).
Ownership of Results and Data. All data and results arising from the Parties’ activities under this Agreement, including clinical and regulatory data and Information generated for regulatory purposes relating to the Product shall be owned by Novartis.
Ownership of Results and Data. All data and results arising from Ideaya’s, its Affiliates’ or sublicensees’ activities under this Agreement, including but not limited to Development, clinical and regulatory data and Information generated for regulatory purposes relating to a Product, will be owned as between the Parties by Ideaya. All data and results arising from Novartis’s, its Affiliates’ or its or their independent contractors’ conduct of the Ongoing Clinical Trial activities under this Agreement, including but not limited to Development, clinical and regulatory data and Information generated for regulatory purposes relating to a Product, will be owned by Novartis and subject to the licenses granted to Ideaya pursuant to Section 2.1 and other rights granted to Ideaya pursuant to this Agreement.
Ownership of Results and Data. All data and results arising from QED’s activities under this Agreement, including but not limited to Development, clinical and regulatory data and Information generated for regulatory purposes relating to a Product will be owned by QED.
Ownership of Results and Data. All data and results arising from Novartis’ activities under this Agreement, including but not limited to clinical and regulatory data and Information generated for regulatory purposes relating to the Product will be owned by Novartis.
Ownership of Results and Data
